<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762307</url>
  </required_header>
  <id_info>
    <org_study_id>JM07001</org_study_id>
    <nct_id>NCT00762307</nct_id>
  </id_info>
  <brief_title>Non-invasive Cooling of Subcutaneous Fat</brief_title>
  <official_title>A Prospective, Multi-Center Clinical Study of Non-Invasive Cooling of Subcutaneous Fat</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeltiq Aesthetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeltiq Aesthetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a non-invasive cooling device to determine if cold&#xD;
      exposure will consistently result in a reduction of subcutaneous fat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate a non-invasive cooling device to determine if cold&#xD;
      exposure will consistently result in a reduction of subcutaneous fat using the Zeltiq Dermal&#xD;
      Cooling device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fat Layer Thickness of the Treated Flank</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>The change in fat layer thickness as demonstrated by measurement of fat layer layer thickness using ultrasound images taken in the treated area and on the contralateral flank (control) at baseline and at the 6 month follow-up. Data collected on the untreated side and the treated side will be combined to determine the normalized change in fat layer thickness for each subject. The mean percent fat layer reduction across all treatment groups will be presented, as well as for each treatment group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects Expressing Satisfaction With the Procedure</measure>
    <time_frame>6 months post-treatment follow-up visit</time_frame>
    <description>Subject satisfaction as determined by the completion of a questionnaire at the 6 month follow-up visit, and, as requested, any other follow-up visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Correctly Identified Pre-treatment Photographs</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Change in the treated vs. untreated areas will be assessed for changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the control and treated flanks. Reviewers will be practicing dermatologists. All reviewers will be blinded to post-treatment vs. baseline and/or untreated flank. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form.Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. Results reflect the percentage of correctly identified images.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Fat Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooling Intensity Factor = 33 Duration = 60 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooling Intensity Factor = 37 Duration = 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooling Intensity Factor = 37 Duration = 45 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooling Intensity Factor = 42 Cooling Duration = 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zeltiq Dermal Cooling Device</intervention_name>
    <description>Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
    <arm_group_label>Treatment Group 1</arm_group_label>
    <arm_group_label>Treatment Group 2</arm_group_label>
    <arm_group_label>Treatment Group 3</arm_group_label>
    <arm_group_label>Treatment Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female subjects &gt; 18 years of age.&#xD;
&#xD;
          2. Subject has clearly visible fat on the flanks, thighs, abdomen, or back.&#xD;
&#xD;
          3. Subject has not had weight change fluctuations exceeding 10 pounds in the preceding&#xD;
             month.&#xD;
&#xD;
          4. Subject has read and signed a written informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject has had liposuction, or another surgical procedure(s) or mesotherapy in area&#xD;
             of intended treatment within the past 2 years.&#xD;
&#xD;
          2. Subject has a known history of subcutaneous injections into the area of intended&#xD;
             treatment (e.g., cortisone) within the past 6 months.&#xD;
&#xD;
          3. Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold&#xD;
             hemoglobinuria.&#xD;
&#xD;
          4. Subject is taking diet pills within the past 6 months.&#xD;
&#xD;
          5. Subject is unable or unwilling to comply with the study requirements.&#xD;
&#xD;
          6. Subject has any dermatological conditions or scars within the location of the test&#xD;
             sites that may interfere with the treatment or evaluation.&#xD;
&#xD;
          7. Subject is currently enrolled in a clinical study of any other unapproved&#xD;
             investigational drug or device.&#xD;
&#xD;
          8. Patient is pregnant or intending to become pregnant in the next 9 months.&#xD;
&#xD;
          9. Patient is lactating or has been lactating in the past 9 months.&#xD;
&#xD;
         10. Any other condition or laboratory value that would, in the professional opinion of the&#xD;
             investigator, potentially affect response or participation in this clinical study, or&#xD;
             would pose an unacceptable risk to the subject.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kerrie Jiang</last_name>
    <role>Study Chair</role>
    <affiliation>Zeltiq Aesthetics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Dublin</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Pleasanton</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>San Ramon</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 27, 2008</study_first_submitted>
  <study_first_submitted_qc>September 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <results_first_submitted>August 24, 2020</results_first_submitted>
  <results_first_submitted_qc>May 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 9, 2021</results_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment Group 1</title>
          <description>Cooling Intensity Factor = 33 Duration = 60 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
        </group>
        <group group_id="P2">
          <title>Treatment Group 2</title>
          <description>Cooling Intensity Factor = 37 Duration = 30 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
        </group>
        <group group_id="P3">
          <title>Treatment Group 3</title>
          <description>Cooling Intensity Factor = 37 Duration = 45 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
        </group>
        <group group_id="P4">
          <title>Treatment Group 4</title>
          <description>Cooling Intensity Factor = 42 Cooling Duration = 30 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Treated with CIF 33 for 60 minutes.</population>
      <group_list>
        <group group_id="B1">
          <title>Treatment Group 1</title>
          <description>Subjects in Treatment Group 1 were treated using a Cooling Intensity Factor (CIF) of 33 for 60 minutes.</description>
        </group>
        <group group_id="B2">
          <title>Treatment Group 2</title>
          <description>Subjects in Treatment Group 2 were treated using CIF 37 for 30 minutes.</description>
        </group>
        <group group_id="B3">
          <title>Treatment Group 3</title>
          <description>Subjects in Treatment Group 3 were treated using CIF 37 for 45 minutes.</description>
        </group>
        <group group_id="B4">
          <title>Treatment Group 4</title>
          <description>Subjects in Treatment Group 4 were treated using CIF 42 for 30 minutes.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="10"/>
            <count group_id="B5" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41" lower_limit="23" upper_limit="65"/>
                    <measurement group_id="B2" value="44" lower_limit="26" upper_limit="56"/>
                    <measurement group_id="B3" value="44" lower_limit="28" upper_limit="55"/>
                    <measurement group_id="B4" value="49" lower_limit="26" upper_limit="65"/>
                    <measurement group_id="B5" value="44" lower_limit="23" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Fat Layer Thickness of the Treated Flank</title>
        <description>The change in fat layer thickness as demonstrated by measurement of fat layer layer thickness using ultrasound images taken in the treated area and on the contralateral flank (control) at baseline and at the 6 month follow-up. Data collected on the untreated side and the treated side will be combined to determine the normalized change in fat layer thickness for each subject. The mean percent fat layer reduction across all treatment groups will be presented, as well as for each treatment group.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The population includes only subjects with evaluable ultrasound data ( &gt;3 valid images at 6 month follow up visit). Group 1 exclusions: 2 Lost To Follow Up and 6 not evaluable; Group 2 exclusions: 1 not evaluable; Group 3 exclusions: 3 not evaluable; Group 4 exclusions: 1 not evaluable and 1 withdrawn from study by Investigator.</population>
        <group_list>
          <group group_id="O1">
            <title>All Groups</title>
            <description>All subjects treated in Groups 1, 2, 3 and 4 are combined for this analysis.</description>
          </group>
          <group group_id="O2">
            <title>Group 1</title>
            <description>CIF 33 for 60 minutes</description>
          </group>
          <group group_id="O3">
            <title>Group 2</title>
            <description>CIF 37 30 minute duration</description>
          </group>
          <group group_id="O4">
            <title>Group 3</title>
            <description>CIF 37 duration 45 minutes</description>
          </group>
          <group group_id="O5">
            <title>Group 4</title>
            <description>CIF 42 30 duration 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fat Layer Thickness of the Treated Flank</title>
          <description>The change in fat layer thickness as demonstrated by measurement of fat layer layer thickness using ultrasound images taken in the treated area and on the contralateral flank (control) at baseline and at the 6 month follow-up. Data collected on the untreated side and the treated side will be combined to determine the normalized change in fat layer thickness for each subject. The mean percent fat layer reduction across all treatment groups will be presented, as well as for each treatment group.</description>
          <population>The population includes only subjects with evaluable ultrasound data ( &gt;3 valid images at 6 month follow up visit). Group 1 exclusions: 2 Lost To Follow Up and 6 not evaluable; Group 2 exclusions: 1 not evaluable; Group 3 exclusions: 3 not evaluable; Group 4 exclusions: 1 not evaluable and 1 withdrawn from study by Investigator.</population>
          <units>percent fat layer change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.7" spread="1.9"/>
                    <measurement group_id="O2" value="-22.6" spread="3.4"/>
                    <measurement group_id="O3" value="-17.8" spread="3.6"/>
                    <measurement group_id="O4" value="-17.5" spread="2.3"/>
                    <measurement group_id="O5" value="-11.1" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>18.7</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>14.9</ci_lower_limit>
            <ci_upper_limit>22.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Expressing Satisfaction With the Procedure</title>
        <description>Subject satisfaction as determined by the completion of a questionnaire at the 6 month follow-up visit, and, as requested, any other follow-up visits.</description>
        <time_frame>6 months post-treatment follow-up visit</time_frame>
        <population>56 subjects completed the questionnaire; 2 subjects were LTFU, 1 subject failed to complete the questionnaire and 1 subject was withdrawn from the study by the Investigator. Four (4) subjects did not respond to one question on the questionnaire; 1 subject did not respond to another question on the questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Study Population</title>
            <description>All subjects treated in Treatment Groups 1,2,3 and 4 are in the Overall Study Population</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group 1</title>
            <description>Cooling Intensity Factor= 33 Duration of Cooling = 60 minutes</description>
          </group>
          <group group_id="O3">
            <title>Treatment Group 2</title>
            <description>Cooling Intensity Factor = 37 Cooling Duration = 30 minutes</description>
          </group>
          <group group_id="O4">
            <title>Treatment Group 3</title>
            <description>Cooling Intensity Factor = 37 Cooling Duration = 45 minutes</description>
          </group>
          <group group_id="O5">
            <title>Treatment Group 4</title>
            <description>Cooling Intensity Factor = 42 Cooling Duration = 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Expressing Satisfaction With the Procedure</title>
          <description>Subject satisfaction as determined by the completion of a questionnaire at the 6 month follow-up visit, and, as requested, any other follow-up visits.</description>
          <population>56 subjects completed the questionnaire; 2 subjects were LTFU, 1 subject failed to complete the questionnaire and 1 subject was withdrawn from the study by the Investigator. Four (4) subjects did not respond to one question on the questionnaire; 1 subject did not respond to another question on the questionnaire.</population>
          <units>percent positive responses</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall satisfaction with treatment experience</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="56"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.1" spread="5.1"/>
                    <measurement group_id="O2" value="84" spread="7.3"/>
                    <measurement group_id="O3" value="81.8" spread="11.6"/>
                    <measurement group_id="O4" value="90.9" spread="8.7"/>
                    <measurement group_id="O5" value="66.7" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agree there is a change to the treated area</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.3" spread="5.7"/>
                    <measurement group_id="O2" value="84" spread="7.3"/>
                    <measurement group_id="O3" value="54.5" spread="15.0"/>
                    <measurement group_id="O4" value="100" spread="0"/>
                    <measurement group_id="O5" value="55.6" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agree change to treated area was improvement</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.9" spread="5.7"/>
                    <measurement group_id="O2" value="95.2" spread="4.7"/>
                    <measurement group_id="O3" value="63.6" spread="14.5"/>
                    <measurement group_id="O4" value="81.8" spread="11.6"/>
                    <measurement group_id="O5" value="55.6" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Expectations were met or exceeded</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="56"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.2" spread="5.9"/>
                    <measurement group_id="O2" value="72" spread="9.0"/>
                    <measurement group_id="O3" value="78.6" spread="12.4"/>
                    <measurement group_id="O4" value="81.8" spread="11.6"/>
                    <measurement group_id="O5" value="66.7" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discomfort was no greater than expected</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="56"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.2" spread="1.8"/>
                    <measurement group_id="O2" value="100" spread="0"/>
                    <measurement group_id="O3" value="90.9" spread="8.7"/>
                    <measurement group_id="O4" value="100" spread="0"/>
                    <measurement group_id="O5" value="100" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Correctly Identified Pre-treatment Photographs</title>
        <description>Change in the treated vs. untreated areas will be assessed for changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the control and treated flanks. Reviewers will be practicing dermatologists. All reviewers will be blinded to post-treatment vs. baseline and/or untreated flank. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form.Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. Results reflect the percentage of correctly identified images.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The analysis population included subjects who had evaluable photos from baseline and the 6 month final follow-up visit. Subjects who did not maintain their weight per protocol requirements were excluded from analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>All Groups</title>
            <description>Treatment Groups 1, 2, 3 and 4 were combined for this analysis.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group 1</title>
            <description>Cooling Intensity Factor = 33 Duration = 60 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Group 2</title>
            <description>Cooling Intensity Factor = 37 Duration = 30 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Group 3</title>
            <description>Cooling Intensity Factor = 37 Duration = 45 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
          </group>
          <group group_id="O5">
            <title>Treatment Group 4</title>
            <description>Cooling Intensity Factor = 42 Cooling Duration = 30 minutes&#xD;
Zeltiq Dermal Cooling Device: Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Correctly Identified Pre-treatment Photographs</title>
          <description>Change in the treated vs. untreated areas will be assessed for changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the control and treated flanks. Reviewers will be practicing dermatologists. All reviewers will be blinded to post-treatment vs. baseline and/or untreated flank. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form.Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. Results reflect the percentage of correctly identified images.</description>
          <population>The analysis population included subjects who had evaluable photos from baseline and the 6 month final follow-up visit. Subjects who did not maintain their weight per protocol requirements were excluded from analysis.</population>
          <units>percent correctly identified images</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" spread="5.2"/>
                    <measurement group_id="O2" value="90.5" spread="7.6"/>
                    <measurement group_id="O3" value="100" spread="0"/>
                    <measurement group_id="O4" value="100" spread="0"/>
                    <measurement group_id="O5" value="83.3" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>sucess percentage</param_type>
            <param_value>91.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.2</dispersion_value>
            <ci_n_sides>1-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected from the time of enrollment though the 6 month follow-up visit, a time period of approximately 8 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group 1</title>
          <description>Subjects from Group 1 were treated using a CIF of 33 for 60 minutes in duration.</description>
        </group>
        <group group_id="E2">
          <title>Treatment Group 2</title>
          <description>Subjects from Group 2 were treated using a CIF of 37 for 30 minutes in duration.</description>
        </group>
        <group group_id="E3">
          <title>Treatment Group 3</title>
          <description>Subjects in Treatment Group 3 were treated using a CIF of 37 for 45 minutes in duration.</description>
        </group>
        <group group_id="E4">
          <title>Treatment Group 4</title>
          <description>Subjects in Treatment Group 4 were treated using a CIF of 42 for 30 minutes in duration.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Muscle spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs</name_or_title>
      <organization>Zeltiq Aesthetics</organization>
      <phone>(925) 621-7462</phone>
      <email>kerrie.jiang@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

